Detalles de la búsqueda
1.
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C.
N Engl J Med
; 389(23): 2125-2139, 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37870968
2.
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
Br J Cancer
; 129(6): 1032-1039, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532830
3.
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.
BMC Cancer
; 23(1): 1046, 2023 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37904096
4.
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
Gastric Cancer
; 26(1): 132-144, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36316527
5.
Phase IIb study of pembrolizumab combined with S-1 + oxaliplatin or S-1 + cisplatin as first-line chemotherapy for gastric cancer.
Cancer Sci
; 113(8): 2814-2827, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35701865
6.
A multicentre retrospective study comparing site-specific treatment with empiric treatment for unfavourable subset of cancer of unknown primary site.
Jpn J Clin Oncol
; 52(12): 1416-1422, 2022 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36047806
7.
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.
Int J Clin Oncol
; 27(9): 1450-1458, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35861943
8.
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial.
Lancet Oncol
; 22(6): 779-789, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33961795
9.
FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer.
Cancer Sci
; 112(1): 314-322, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33075166
10.
A 10-Item Frailty Index Based on a Comprehensive Geriatric Assessment (FI-CGA-10) in Older Adults with Cancer: Development and Construct Validation.
Oncologist
; 26(10): e1751-e1760, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34216413
11.
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer.
BMC Cancer
; 21(1): 1159, 2021 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34715820
12.
OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody.
Br J Cancer
; 122(10): 1507-1517, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32203221
13.
Multicenter Cohort Study to Assess the Association between Changes on Imaging and Outcome after Regorafenib Treatment (KSCC1603).
Oncology
; 98(10): 719-726, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32640458
14.
Treatment strategies for neuroendocrine carcinoma of the upper digestive tract.
Int J Clin Oncol
; 25(5): 842-850, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32036480
15.
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.
Int J Clin Oncol
; 25(4): 614-621, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31838590
16.
Phase I dose-escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors.
Cancer Sci
; 110(4): 1340-1351, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30724423
17.
Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer.
Cancer Sci
; 110(11): 3565-3572, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31520559
18.
Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancer.
Cancer Sci
; 110(3): 1032-1043, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30657223
19.
Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients.
Gastric Cancer
; 22(5): 988-998, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30788749
20.
Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial.
Gastric Cancer
; 22(4): 817-827, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30515672